St. Luke's Hospital of Kansas City

Kansas City, Missouri 64111

We've found

3 trials

at this facility

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Kansas City, MO

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

Status: Enrolling
Updated: 12/31/1969

from

Kansas City, MO

Surveillance HeartCare® Outcomes Registry

Status: Enrolling, Phase
Updated: 12/31/1969

from

Kansas City, MO

Use our guide to learn which trials are right for you!